CD163 and neoplasm: Previous studies have highlighted the enrichment of CD163+ macrophages in inflammation and tumor occurrence microenvironments (78), with anti-inflammatory or anti-tumor drugs targeting CD163+ macrophages showing promising therapeutic effects in animal models (79).